Combined HDR brachytherapy boost plus external beam radiotherapy by IMRT versus external beam radiotherapy alone IMRT in intermediate- and high-risk prostate cancer: Dosimetric analysis from a randomized control trial.

被引：0
|
作者：
Annamalai, Manikandan [1 ]
Ma, Laviraj [1 ]
Kunhiparambath, Haresh [1 ]
Sharma, Dayanand [1 ]
Gupta, Subhash [1 ]
Mallick, Supriya [1 ]
Julka, Pramod Kumar [1 ]
Rath, Goura Kishor [1 ]
机构：
[1] All India Inst Med Sci, New Delhi, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.134
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
134
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Deformable Registration and Dose Accumulation for Image-guided HDR Interstitial Brachytherapy (IG-BT) Boost and External Beam Pelvic IMRT (EB-IMRT) for Intermediate and High-risk Prostate Cancer Patients
    Tyagi, N.
    Sebastian, E.
    Liang, J.
    Yan, D.
    Ghilezan, M.
    Martinez, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S731 - S732
  • [42] Follow-up analysis of combined HDR-brachytherapy and external beam radiotherapy for prostate cancer patients
    Siebert, F. A.
    Juergens, L.
    Dunst, J.
    Jiang, P.
    Nuernberg, N.
    Galalae, R.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S561 - S561
  • [43] Adjuvant external beam radiotherapy combined with brachytherapy for intermediate-risk cervical cancer
    Agusti, Nuria
    Viveros-Carreno, David
    Melamed, Alexander
    Pareja, Rene
    Kanbergs, Alexa
    Wu, Chi-Fang
    Nitecki, Roni
    Colbert, Lauren
    Rauh-Hain, Jose Alejandro
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (08) : 1149 - 1155
  • [44] Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer
    Yang, David D.
    Muralidhar, Vinayak
    Nguyen, Paul L.
    Buzurovic, Ivan
    Martin, Neil E.
    Mouw, Kent W.
    Devlin, Phillip M.
    Quoc-Dien Trinh
    Orio, Peter F., III
    King, Martin T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (04): : 904 - 911
  • [45] Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone
    Faria, Sergio
    Dal Pra, Alan
    Cury, Fabio
    David, Marc
    Duclos, Marie
    Freeman, Carolyn R.
    Souhami, Luis
    RADIOTHERAPY AND ONCOLOGY, 2011, 101 (03) : 486 - 489
  • [46] Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone
    Dal Pra, A.
    Faria, S.
    Cury, F. L.
    David, M.
    Duclos, M.
    Shenouda, G.
    Souhami, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [47] High dose rate brachytherapy plus external beam radiotherapy for localized prostate cancer
    Strouthos, I.
    Chatzikonstantinou, G.
    Tselis, N.
    Milickovic, N.
    Papaioannou, S.
    Butt, S.
    Grosu, A. L.
    Baltas, D.
    Zamboglou, N.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S427 - S427
  • [48] COMPARISON OF CLINICAL OUTCOME IN INTERMEDIATE RISK PROSTATE CANCER PATIENT TREATED WITH PERMANENT SEEDS IMPLANT ALONE OR EXTERNAL BEAM RADIOTHERAPY WITH HDR BOOST
    Vigneault, E.
    Martin, A. -G.
    Laflamme, N.
    Beaulieu, L.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S2 - S2
  • [49] Survival outcomes of dose-escalated external beam radiotherapy (DE-EBRT) versus combined brachytherapy for intermediate- and high-risk prostate cancer using the National Cancer Data Base
    Amini, Arya
    Jackson, Matthew Wayne
    Yeh, Norman
    Waxweiler, Timothy V.
    Jones, Bernard
    Maroni, Paul
    Kavanagh, Brian D.
    Raben, David
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [50] Health-related quality of life after IMRT or IMRT plus HDR brachytherapy for intermediate or high-risk prostate cancer: Five-year results of a prospective trial.
    Guix, Benjamin
    Maria Lacorte, Teresa
    Maria Bartrina, Jose
    Ignacio Tello, Jose
    Guix, Ines
    Galdon, Guillermo
    Espino, Marc
    Guix, Teresa
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345